| Medical and Health Sciences | Lifetime | 731 | IT 20 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 346 | IT 26 | 99.93 |
| Cardiology and Cardiovascular Medicine | Lifetime | 123 | IT 7 | 99.87 |
| Complementary and Alternative Medicine | Lifetime | 122 | IT 3 | 99.45 |
| Biochemistry | Lifetime | 604 | IT 14 | 90.58 |
| Nephrology | Lifetime | 698 | IT 33 | 90.56 |
| Endocrine and Autonomic Systems | Lifetime | 728 | IT 15 | 83.44 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 71 | IT 8 | 99.69 |
| Complementary and Alternative Medicine | 2021-2025 | 167 | IT 3 | 91.42 |
| Surgery | 2021-2025 | 892 | IT 61 | 91.78 |
| Nephrology | 2021-2025 | 220 | IT 12 | 87.70 |
| Heart Rate Variability and Autonomic Control | Lifetime | 24 | IT 5 | 99.82 |
| Blood Pressure and Hypertension Studies | Lifetime | 44 | IT 6 | 99.77 |
| Cardiovascular Health and Disease Prevention | Lifetime | 58 | IT 4 | 99.58 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 32 | IT 5 | 99.38 |
| Cardiovascular and exercise physiology | Lifetime | 61 | IT 3 | 99.57 |
| Hormonal Regulation and Hypertension | Lifetime | 182 | IT 10 | 99.00 |
| Cardiovascular Disease and Adiposity | Lifetime | 173 | IT 7 | 99.03 |
| Sodium Intake and Health | Lifetime | 51 | IT 4 | 98.93 |
| Heart rate and cardiovascular health | Lifetime | 14 | IT 5 | 98.76 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 186 | IT 7 | 98.55 |
| Cardiovascular Function and Risk Factors | Lifetime | 560 | IT 32 | 99.00 |
| Non-Invasive Vital Sign Monitoring | Lifetime | 237 | IT 30 | 97.46 |
| Cardiac Health and Mental Health | Lifetime | 265 | IT 8 | 97.99 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 178 | IT 13 | 96.11 |
| Long-Term Effects of COVID-19 | Lifetime | 930 | IT 156 | 94.39 |
| Pharmacology and Obesity Treatment | Lifetime | 298 | IT 27 | 96.66 |
| Hemodynamic Monitoring and Therapy | Lifetime | 787 | IT 44 | 96.11 |
| Alcohol Consumption and Health Effects | Lifetime | 728 | IT 34 | 95.46 |
| Case Reports on Hematomas | Lifetime | 412 | IT 24 | 80.84 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 5 | IT 3 | 99.69 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 12 | IT 4 | 98.94 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 25 | IT 4 | 99.47 |
| Heart rate and cardiovascular health | 2021-2025 | 2 | IT 1 | 98.56 |
| Cardiac Health and Mental Health | 2021-2025 | 79 | IT 3 | 96.55 |
| Alcohol Consumption and Health Effects | 2021-2025 | 94 | IT 8 | 95.16 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 59 | IT 7 | 95.03 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 878 | IT 114 | 94.62 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 101 | IT 12 | 91.13 |
| Sodium Intake and Health | 2021-2025 | 101 | IT 6 | 91.02 |
| Nutritional Studies and Diet | 2021-2025 | 877 | IT 61 | 91.47 |
| Cardiovascular and exercise physiology | 2021-2025 | 494 | IT 29 | 91.20 |
| Hormonal Regulation and Hypertension | 2021-2025 | 346 | IT 29 | 89.51 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 970 | IT 9 | 42.81 |